<DOC>
	<DOCNO>NCT02231125</DOCNO>
	<brief_summary>-IgA nephropathy common primary glomerular disease China , Huangkui Capsule single medicament traditional Chinese medicine consist Abelmoschus manihot widely use treat kidney disease . The purpose study evaluate safety efficacy Abelmoschus manihot treat IgA nephropathy large scale sample long time take .</brief_summary>
	<brief_title>Efficacy Safety Abelmoschus Manihot IgA Nephropathy</brief_title>
	<detailed_description>The test complete .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Clinical diagnose chronic nephritic syndrome IgA nephropathy diagnose kidney biopsy Aged 18 65 years，male female Blood pressure ≤140/90mmHg Estimated Glomerular Filtration Rate ( eGFR ) ≥45ml/min/1.73 m2 24hour proteinuria range 0.5g3.0g Obtaining sign informed consent patient Secondary IgA nephropathy Be allergic Huangkui Capsule Losartan potassium tablet Taken Huangkui Capsule ACEI ARB last 6 week Taken glucocorticoid , immunosuppressant common threewingnut root drug immunosuppressive action last 12 month Blood pressure ＜90/60mmHg Serum potassium level &gt; 5.5mmol / L Serum albumin level &lt; 30g / L Lactation , pregnancy plan pregnancy study period Unilateral bilateral renal artery stenosis Combined severe primary disease heart , brain , liver hematopoietic system , serious disease affect patient 's life Participating another clinical study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Abelmoschus manihot</keyword>
	<keyword>IgA Nephropathy</keyword>
	<keyword>proteinuria</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
</DOC>